Affymetrix Q2 Revenues Grow 4 Percent | GenomeWeb

NEW YORK (GenomeWeb) - Affymetrix reported after the close of the market Wednesday second quarter revenue growth of 4 percent, driven by increases in product revenues and in its genetic analysis business.

For the three months ended June 30, the company's revenues increased to $89 million from $85.4 million in the year-ago quarter. On a constant currency basis, its revenues increased almost 8 percent year over year, and beat the average Wall Street estimate of $88.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.